LAG3 and neoplasm: LAG-3 expression in immune cells was more common in high-grade, high-intermediate risk, high-risk, and advanced/metastatic subgroups and was relevant to lymphovascular space invasion (60).LAG-3 expression was more prevalent in POLEmut and MMRd EC than in p53abn and p53wt EC in tumor cells Positive LAG-3 expression may be a predictor of improved RFS (60).